Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KAYI Healthcare appears to be a healthcare operating business rather than a drug-development biotech company. Publicly accessible evidence indicates it has been associated with specialist medical practice activity in the UK and with oncology-related service delivery in East Africa, including a chemotherapy unit partnership at Consolata Hospital Mathari and links to Nairobi Radiotherapy and Cancer Centre. Trade-data sources also suggest KAYI-affiliated East African entities have imported medical and hospital equipment. However, there is limited high-quality public information on its corporate structure, product portfolio, ownership, financing, or any proprietary therapeutic pipeline. The best-supported view is that KAYI Healthcare is a healthcare-services and medical-supply related organization with oncology service involvement, not a classic biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KAYI Healthcare.